March 22, 2018
Now Available From Onco360 - The New IMBRUVICA® pill is now available as a one pill, once a day treatment.
August 1, 2017
Onco360 announces selection to highly limited pharmacy network for NERLYNX.
April 14, 2016
Onco360 announces selection to highly limited pharmacy network for VENCLEXTA.
March 22, 2016
Limited distribution medication XALKORI (crizotinib) receives approval for certain NSCLC patients.
March 7, 2016
Limited distribution breast cancer medication IBRANCE approved for additional indication.
February 9, 2016
Imatinib Mesylate (generic Gleevec) was recently approved for 7 indications.
January 25, 2016
Combination therapy receives accelerated approval for new indication. OPDIVO also receives additional indication as a single therapy.
October 7, 2015
Onco360 Selected for Lonsurf Limited Distribution Pharmacy Network
June 16, 2015
Onco360 Receives URAC Specialty Pharmacy Accreditation...
February 9, 2015
Newly Approved Ibrance® (palbociclib) From Pfizer Available Through Onco360; Company Again Selected as Limited Distribution Pharmacy Provider
September 24–26, 2018
Join us at the 2018 NASP Annual Meeting and Educational Conference.
October 22–25, 2018
Can we talk? Schedule a meeting with Onco360 at this year’s 2018 AMCP Nexus.
November 15–18, 2018
Join us at the 9th Annual Navigation & Survivorship Conference hosted by AONN+.
December 1–4, 2018
Can we talk? Schedule a meeting with Onco360 at this year’s 2018 ASH Annual Meeting & Exposition.
December 4–8, 2018
Can we talk? Schedule a meeting with Onco360 at this year’s 2018 San Antonio Breast Cancer Symposium.